Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. On Friday 08/02/ the closing price of the Hepion Pharmaceuticals Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 08/02/. Hepion Pharmaceuticals Inc. · AFTER HOURS PM EDT 09/05/24 · % · AFTER HOURS Vol Get the latest Hepion Pharmaceuticals Inc (HEPA) real-time quote, historical performance, charts, and other financial information to help you make more. Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases.
Recent News & Updates · Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. · HEPA Stock. What is the current stock price of Hepion Pharmaceuticals (HEPA)?. The current stock price of Hepion Pharmaceuticals (HEPA) is $ as of September 6, Recent News Shares of Hepion Pharmaceuticals Inc. rocketed 57% in active trading to pace all premarket gainers, after the biopharmceutical company announced. News · Hepion Pharmaceuticals, Pharma Two B Announce SEC Filing for Proposed Merger Transaction. MT Newswires · Express News | Pharma Two B and Hepion. (NASDAQ: HEPA) Hepion Pharmaceuticals currently has 5,, outstanding shares. With Hepion Pharmaceuticals stock trading at $ per share, the total value. Stock Quote ; Price. $ ; Volume. 3, ; Open. $ ; Previous Close. $ ; Day Range. $$ Hepion Pharmaceuticals Inc HEPA:NASDAQ ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High Analysts' recommendations: Hepion Pharmaceuticals, Inc. · Cantor Fitzgerald Starts Hepion Pharmaceuticals at Overweight With $ Price Target. · HEPION. EDISON, N.J., Feb. 16, (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on artificial. The Hepion Pharmaceuticals, Inc. stock price fell by % on the last day (Tuesday, 3rd Sep ) from $ to $ During the last trading day the stock. On Friday 08/02/ the closing price of the Hepion Pharmaceuticals Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 08/02/.
Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. Find the latest Hepion Pharmaceuticals, Inc. (HEPA) stock quote, history, news and other vital information to help you with your stock trading and investing. Recent News Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease treatment. The merger. View Hepion Pharmaceuticals (HEPA) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Discover real-time Hepion Pharmaceuticals, Inc. Common Stock (HEPA) stock prices, quotes, historical data, news, and Insights for informed trading and. Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals. Insider Buying: Robert Foster Acquires 1, Shares of Hepion Pharmaceuticals Inc. On September 15, , Robert Foster, the CEO, CSO, and Director of Hepion. HEPA Hepion Pharmaceuticals Inc. 27, $ $ (%). Today. Watchers, 27, Wk Low, $ Wk High, $ Market Cap, $M. Hepion Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The Company focuses on the development of targeted therapies for liver disease.
Hepion Pharmaceuticals Inc · Latest News · Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer · Why Is. Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. Stock Quote. Nasdaq:HEPA$▽ $%. Price. $ Change. Hepion ends Phase 2 study for NASH drug due to cash restraints · Madrigal announces US launch of NASH/MASH drug Rezdiffra · NASH drug market expected to surpass. Stay up-to-date on Hepion Pharmaceuticals, Inc. Common Stock (HEPA) news with the latest updates, breaking headlines, news articles, and more from around. Hepion Pharmaceuticals Inc News & Analysis · Hepion Pharmaceuticals faces Nasdaq delisting over share price · Pharma Two B and Hepion Pharmaceuticals file for.
Research Hepion Pharmaceuticals' (Nasdaq:HEPA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth. Hepion Pharmaceuticals ; Profitability Metrics. Gross Margin (ttm). N/A ; Revenue and Earnings Metrics. Revenue (ttm). N/A ; Cash and Debt Metrics. Total Cash. Hepion Pharmaceuticals Inc. · Breaking News · Analysts weigh in on Tesla stock price target, deliveries and robotaxis · Single Best Trade: Fund manager at $
Mad Money Picks | How Do You Get Paid For Plasma